Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Theranostics Market Report by Disease Type (Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, and Others), Technology (Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, and Others), End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), Region and Competitive Landscape (Market Share, Business Overview, Products Offered, Business Strategies, SWOT Analysis and Major News and Events) 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A22828
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Theranostics Market – Introduction
4.1 What is Theranostics?
4.2 Major Diseases for Which Theranostics is Used
4.2.1 Neurological Disorders
4.2.2 Cardiovascular Diseases
4.2.3 Immunological Disorders
4.2.4 Oncology Diseases
4.3 Major Technologies Used for Theranostics
4.3.1 Polymerase Chain Reaction
4.3.2 Immunohistochemistry
4.3.3 In-Situ Hybridization
4.3.4 Sequencing
4.4 Industry Trends
4.5 Competitive Intelligence
5 Global Theranostics Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 Global Theranostics Market - Breakup by Disease Type
6.1 Neurological Disorders
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.1.4 Market Breakup by Technology
6.1.5 Market Breakup by End User
6.2 Cardiovascular Diseases
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
6.2.4 Market Breakup by Technology
6.2.5 Market Breakup by End User
6.3 Immunological Disorders
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Forecast (2024-2032)
6.3.4 Market Breakup by Technology
6.3.5 Market Breakup by End User
6.4 Oncology Diseases
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2018-2023)
6.4.3 Market Forecast (2024-2032)
6.4.4 Market Breakup by Technology
6.4.5 Market Breakup by End User
6.5 Others
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2018-2023)
6.5.3 Market Forecast (2024-2032)
6.6 Attractive Investment Proposition by Disease Type
7 Global Theranostics Market - Breakup by Technology
7.1 Polymerase Chain Reaction
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.1.4 Market Breakup by Disease Type
7.1.5 Market Breakup by End User
7.2 Immunohistochemistry
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
7.2.4 Market Breakup by Disease Type
7.2.5 Market Breakup by End User
7.3 In-Situ Hybridization
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Forecast (2024-2032)
7.3.4 Market Breakup by Disease Type
7.3.5 Market Breakup by End User
7.4 Sequencing
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2018-2023)
7.4.3 Market Forecast (2024-2032)
7.4.4 Market Breakup by Disease Type
7.4.5 Market Breakup by End User
7.5 Others
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2018-2023)
7.5.3 Market Forecast (2024-2032)
7.6 Attractive Investment Proposition by Technology
8 Global Theranostics Market - Breakup by End User
8.1 Hospitals & Clinics
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Forecast (2024-2032)
8.1.4 Market Breakup by Disease Type
8.1.5 Market Breakup by Technology
8.2 Diagnostic Laboratories
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
8.2.4 Market Breakup by Disease Type
8.2.5 Market Breakup by Technology
8.3 Others
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Forecast (2024-2032)
8.4 Attractive Investment Proposition by End User
9 Global Theranostics Market – Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Drivers
9.1.1.2 Historical and Current Market Trends (2018-2023)
9.1.1.3 Market Breakup by Disease Type
9.1.1.4 Market Breakup by Technology
9.1.1.5 Market Breakup by End User
9.1.1.6 Key Players
9.1.1.7 Market Forecast (2024-2032)
9.1.2 Canada
9.1.2.1 Market Drivers
9.1.2.2 Historical and Current Market Trends (2018-2023)
9.1.2.3 Market Breakup by Disease Type
9.1.2.4 Market Breakup by Technology
9.1.2.5 Market Breakup by End User
9.1.2.6 Key Players
9.1.2.7 Market Forecast (2024-2032)
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Drivers
9.2.1.2 Historical and Current Market Trends (2018-2023)
9.2.1.3 Market Breakup by Disease Type
9.2.1.4 Market Breakup by Technology
9.2.1.5 Market Breakup by End User
9.2.1.6 Key Players
9.2.1.7 Market Forecast (2024-2032)
9.2.2 Japan
9.2.2.1 Market Drivers
9.2.2.2 Historical and Current Market Trends (2018-2023)
9.2.2.3 Market Breakup by Disease Type
9.2.2.4 Market Breakup by Technology
9.2.2.5 Market Breakup by End User
9.2.2.6 Key Players
9.2.2.7 Market Forecast (2024-2032)
9.2.3 India
9.2.3.1 Market Drivers
9.2.3.2 Historical and Current Market Trends (2018-2023)
9.2.3.3 Market Breakup by Disease Type
9.2.3.4 Market Breakup by Technology
9.2.3.5 Market Breakup by End User
9.2.3.6 Key Players
9.2.3.7 Market Forecast (2024-2032)
9.2.4 South Korea
9.2.4.1 Market Drivers
9.2.4.2 Historical and Current Market Trends (2018-2023)
9.2.4.3 Market Breakup by Disease Type
9.2.4.4 Market Breakup by Technology
9.2.4.5 Market Breakup by End User
9.2.4.6 Key Players
9.2.4.7 Market Forecast (2024-2032)
9.2.5 Australia
9.2.5.1 Market Drivers
9.2.5.2 Historical and Current Market Trends (2018-2023)
9.2.5.3 Market Breakup by Disease Type
9.2.5.4 Market Breakup by Technology
9.2.5.5 Market Breakup by End User
9.2.5.6 Key Players
9.2.5.7 Market Forecast (2024-2032)
9.2.6 Indonesia
9.2.6.1 Market Drivers
9.2.6.2 Historical and Current Market Trends (2018-2023)
9.2.6.3 Market Breakup by Disease Type
9.2.6.4 Market Breakup by Technology
9.2.6.5 Market Breakup by End User
9.2.6.6 Key Players
9.2.6.7 Market Forecast (2024-2032)
9.2.7 Others
9.2.7.1 Historical and Current Market Trends (2018-2023)
9.2.7.2 Market Forecast (2024-2032)
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Drivers
9.3.1.2 Historical and Current Market Trends (2018-2023)
9.3.1.3 Market Breakup by Disease Type
9.3.1.4 Market Breakup by Technology
9.3.1.5 Market Breakup by End User
9.3.1.6 Key Players
9.3.1.7 Market Forecast (2024-2032)
9.3.2 France
9.3.2.1 Market Drivers
9.3.2.2 Historical and Current Market Trends (2018-2023)
9.3.2.3 Market Breakup by Disease Type
9.3.2.4 Market Breakup by Technology
9.3.2.5 Market Breakup by End User
9.3.2.6 Key Players
9.3.2.7 Market Forecast (2024-2032)
9.3.3 United Kingdom
9.3.3.1 Market Drivers
9.3.3.2 Historical and Current Market Trends (2018-2023)
9.3.3.3 Market Breakup by Disease Type
9.3.3.4 Market Breakup by Technology
9.3.3.5 Market Breakup by End User
9.3.3.6 Key Players
9.3.3.7 Market Forecast (2024-2032)
9.3.4 Italy
9.3.4.1 Market Drivers
9.3.4.2 Historical and Current Market Trends (2018-2023)
9.3.4.3 Market Breakup by Disease Type
9.3.4.4 Market Breakup by Technology
9.3.4.5 Market Breakup by End User
9.3.4.6 Key Players
9.3.4.7 Market Forecast (2024-2032)
9.3.5 Spain
9.3.5.1 Market Drivers
9.3.5.2 Historical and Current Market Trends (2018-2023)
9.3.5.3 Market Breakup by Disease Type
9.3.5.4 Market Breakup by Technology
9.3.5.5 Market Breakup by End User
9.3.5.6 Key Players
9.3.5.7 Market Forecast (2024-2032)
9.3.6 Others
9.3.6.1 Historical and Current Market Trends (2018-2023)
9.3.6.2 Market Forecast (2024-2032)
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Drivers
9.4.1.2 Historical and Current Market Trends (2018-2023)
9.4.1.3 Market Breakup by Disease Type
9.4.1.4 Market Breakup by Technology
9.4.1.5 Market Breakup by End User
9.4.1.6 Key Players
9.4.1.7 Market Forecast (2024-2032)
9.4.2 Mexico
9.4.2.1 Market Drivers
9.4.2.2 Historical and Current Market Trends (2018-2023)
9.4.2.3 Market Breakup by Disease Type
9.4.2.4 Market Breakup by Technology
9.4.2.5 Market Breakup by End User
9.4.2.6 Key Players
9.4.2.7 Market Forecast (2024-2032)
9.4.3 Others
9.4.3.1 Historical and Current Market Trends (2018-2023)
9.4.3.2 Market Forecast (2024-2032)
9.5 Middle East
9.5.1 Market Drivers
9.5.2 Historical and Current Market Trends (2018-2023)
9.5.3 Market Breakup by Disease Type
9.5.4 Market Breakup by Technology
9.5.5 Market Breakup by End User
9.5.6 Key Players
9.5.7 Market Forecast (2024-2032)
9.6 Africa
9.6.1 Market Drivers
9.6.2 Historical and Current Market Trends (2018-2023)
9.6.3 Market Breakup by Disease Type
9.6.4 Market Breakup by Technology
9.6.5 Market Breakup by End User
9.6.6 Key Players
9.6.7 Market Forecast (2024-2032)
9.7 Attractive Investment Proposition by Region
10 Market Dynamics
10.1 Market Driving Factors
10.1.1 Growing Cases of Cancer and Chronic Diseases
10.1.2 Rising Demand for Personalized Medicine
10.1.3 Novel Biomakers and Molecular Targets Emergence
10.2 Market Restraining Factors
10.2.1 Associated High Cost
10.2.2 Limited Reimbursement Policies
10.2.3 Complex Regulatory Policies
10.3 Market Opportunities
10.3.1 Innovation in Theranostics Technologies
10.3.2 Growing Application in Non-Oncological Diseases
10.3.3 Collaboration Among Companies
10.3.4 Integration of AI and Machine Learning
11 Key Technological Trends & Development
11.1 Nano Technology
11.2 Imaging Technologies (PET, SPECT, MRI, Others)
11.3 Artificial Intelligence and Machine Learning
11.4 Liquid Biopsies
11.5 3D Bioprinting Technologies
12 Government Regulations and Strategies
12.1 Food and Drug Administration (FDA)
12.2 Radiological Society of North America
12.3 ISO 13485
12.4 Australian Digital Health Agency
13 Recent Industry News
13.1 UCLA Health Inaugurated the Theranostics Center To Treat Advanced Cancer
13.2 InHealth Announced Launch of UK's First Relocatable Radioligand Therapy Service
13.3 MGI Partnered With ALACRiS Theranostics to Launch Customer Experience Center (CEC) in Berlin, Germany
13.4 South Korea's Asan Medical Center (AMC)Opened Country's First Theranostics Center
13.5 Icon Group Announced Launched of Theranostics
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Value Chain Analysis
16 Global Theranostics Market – Competitive Landscape
16.1 Overview
16.2 Market Structure
16.3 Market Share by Key Players
16.4 Market Player Positioning
16.5 Top Winning Strategies
16.6 Competitive Dashboard
16.7 Company Evaluation Quadrant
17 Competitive Landscape
17.1 Abbott Laboratories
17.1.1 Business Overview
17.1.2 Products Offered
17.1.3 Business Strategies
17.1.4 SWOT Analysis
17.1.5 Major News and Events
17.2 Agilent Technologies Inc.
17.2.1 Business Overview
17.2.2 Products Offered
17.2.3 Business Strategies
17.2.4 SWOT Analysis
17.2.5 Major News and Events
17.3 AmeriPath Inc (Quest Diagnostics Incorporated)
17.3.1 Business Overview
17.3.2 Products Offered
17.3.3 Business Strategies
17.3.4 SWOT Analysis
17.3.5 Major News and Events
17.4 Beckman Coulter Inc. (Danaher Corporation)
17.4.1 Business Overview
17.4.2 Products Offered
17.4.3 Business Strategies
17.4.4 SWOT Analysis
17.4.5 Major News and Events
17.5 Becton, Dickinson and Company
17.5.1 Business Overview
17.5.2 Products Offered
17.5.3 Business Strategies
17.5.4 SWOT Analysis
17.5.5 Major News and Events
17.6 F. Hoffmann-La Roche AG
17.6.1 Business Overview
17.6.2 Products Offered
17.6.3 Business Strategies
17.6.4 SWOT Analysis
17.6.5 Major News and Events
17.7 General Electric Company
17.7.1 Business Overview
17.7.2 Products Offered
17.7.3 Business Strategies
17.7.4 SWOT Analysis
17.7.5 Major News and Events
17.8 Illumina Inc
17.8.1 Business Overview
17.8.2 Products Offered
17.8.3 Business Strategies
17.8.4 SWOT Analysis
17.8.5 Major News and Events
17.9 Myriad Genetics Inc.
17.9.1 Business Overview
17.9.2 Products Offered
17.9.3 Business Strategies
17.9.4 SWOT Analysis
17.9.5 Major News and Events
17.10 Pfizer Inc
17.10.1 Business Overview
17.10.2 Products Offered
17.10.3 Business Strategies
17.10.4 SWOT Analysis
17.10.5 Major News and Events
17.11 Qiagen N.V.
17.11.1 Business Overview
17.11.2 Products Offered
17.11.3 Business Strategies
17.11.4 SWOT Analysis
17.11.5 Major News and Events
17.12 Thermo Fisher Scientific Inc.
17.12.1 Business Overview
17.12.2 Products Offered
17.12.3 Business Strategies
17.12.4 SWOT Analysis
17.12.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
18 Strategic Recommendations
19 Appendix
Purchase Options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
Read More
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested
Read More
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
Read More
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
Read More
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
Read More
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
Read More
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
Read More
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
Read More
The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.
Read More
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Read More
The report is excellent and has good amount of data and our team is extremely happy with the information provided.
Read More
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.
Read More